Equities

Revenio Group Oyj

Revenio Group Oyj

Actions
Health CareMedical Equipment and Services
  • Price (EUR)38.38
  • Today's Change0.76 / 2.02%
  • Shares traded33.95k
  • 1 Year change-12.73%
  • Beta1.3698
Data delayed at least 15 minutes, as of Jan 27 2023 17:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

  • Revenue in EUR (TTM)92.48m
  • Net income in EUR21.62m
  • Incorporated2001
  • Employees191.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sedana Medical AB (publ)11.91m-4.85m223.98m92.00--2.35--18.81-0.5544-0.55441.3610.730.15891.718.551,482,511.00-6.47-5.21-6.85-5.5669.7954.42-40.74-23.8314.03--0.0081--12.2637.69-113.59--86.19--
Bactiguard Holding AB20.30m-5.72m287.08m210.00--7.10--14.14-1.83-1.836.4914.590.2693.324.991,209,420.00-7.59-3.03-8.24-3.4644.5654.81-28.19-11.313.30-17.820.3211---3.756.89-53.10---0.3178--
Detection Technology Oyj-100.00bn-100.00bn297.52m463.00--4.14----------4.90----------16.29--22.31--49.23--12.823.09--0.201942.3310.123.5338.21-3.09-3.356.96
Medistim ASA43.06m9.08m374.44m116.0041.0911.5933.278.705.345.3425.3318.941.160.97025.773,990,121.0024.5622.1629.4527.7978.0577.2121.0918.823.35182.430.037674.6417.669.7731.0018.38--16.47
CellaVision AB58.13m11.23m535.45m234.0047.699.9036.299.215.275.2727.3025.400.81021.727.643,255,925.0015.6518.7218.5222.7269.2870.7019.3221.741.8514.750.155229.0419.9616.3740.0715.9529.895.92
Xvivo Perfusion AB32.99m2.67m551.50m118.00206.994.4783.7016.711.011.0112.4846.740.26541.244.904,017,837.002.15-0.30342.27-0.325871.7573.368.08-1.184.82--0.004--43.6613.34118.6440.2735.61--
Synsam AB (publ)459.70m28.92m570.12m3.25k19.712.506.721.242.162.1634.3317.020.66592.3414.05--4.20--5.75--76.35--6.31--0.59712.160.621--22.67--126.15------
BICO Group AB186.07m3.64m658.50m1.27k180.330.933523.083.540.59230.592332.54114.410.23720.91263.762,342,135.000.4586--0.5044--81.72--1.93--1.55--0.2002--------------
Arjo AB (publ)890.75m39.90m921.51m6.69k24.751.456.771.031.641.6436.6427.990.64843.796.14--2.903.444.525.3342.2044.394.475.340.73697.510.45342.6410.025.35-39.7630.52--11.20
Biotage AB136.04m21.33m961.81m510.0045.206.7432.367.073.613.6123.0424.230.80022.307.023,066,399.0012.5514.8715.3317.8061.2961.3715.6817.181.7511.600.109744.4712.7913.0316.9217.183.334.40
Revenio Group Oyj92.48m21.62m1.02bn191.0047.3511.8740.0911.070.81060.81063.473.230.76787.208.33502,597.8017.8716.3121.1719.9850.9651.8823.2722.281.78--0.205469.8429.0027.4429.6324.259.80-14.40
Ossur hf658.03m43.40m1.99bn3.67k46.723.5721.703.020.74880.748811.499.800.56572.416.731,334,343.003.805.594.866.5062.1363.036.718.700.575511.480.424910.0714.166.65929.844.631.66--
Data as of Jan 27 2023. Currency figures normalised to Revenio Group Oyj's reporting currency: Euro EUR

Institutional shareholders

22.05%Per cent of shares held by top holders
HolderShares% Held
Threadneedle Asset Management Ltd.as of 31 Dec 20211.16m4.34%
SEB Investment Management ABas of 31 Dec 2022777.55k2.91%
The Vanguard Group, Inc.as of 05 Jan 2023665.67k2.50%
Groupama Asset Management SAas of 31 Dec 2021612.27k2.30%
Capital Research & Management Co. (World Investors)as of 31 Dec 2022610.30k2.29%
Norges Bank Investment Managementas of 31 Dec 2021542.28k2.03%
Keskin�inen El�kevakuutusyhti� Ilmarinenas of 28 Feb 2022474.92k1.78%
Teknik Innovation Norden Fonder ABas of 30 Jun 2021367.87k1.38%
SEB Wealth Management Finland Ltd.as of 31 May 2022348.12k1.31%
Handelsbanken Fonder ABas of 31 Dec 2022326.21k1.22%
More ▼
Data from 30 Jun 2021 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.